Dr. Robert J. Fortuna, MD

Dr. Fortuna practices at Highland Hospital of Rochester in Rochester, New York.

Dr. Fortuna's NPI, 1598870842, was assigned on August 19, 2006. Dr. Fortuna graduated from Geisel School Of Medicine At Dartmouth in 2002. Dr. Fortuna's Massachusetts license number on file is 229638.

Dr. Fortuna's primary practice is Highland Hospital of Rochester, at 913 Culver Rd, Rochester, NY 14609 in Monroe County. The practice phone is (585) 784-7848.

Dr. Fortuna's primary practice is Highland Hospital of Rochester in Rochester, New York. Dr. Fortuna is also affiliated with Highland Hospital. The medical group on file is Highland Hospital. Dmand AI also links Dr. Fortuna to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fortuna practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Fortuna's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Fortuna is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fortuna's licenses on file in 2 states: Massachusetts and New York.

Dmand AI lists acid reflux, acne, acute sinusitis, acute skin infection, aneurysm, bipolar disorder, chronic anemia and chronic diabetes among the conditions Dr. Fortuna treats.

CMS data shows 183 Medicare services from Dr. Fortuna across 4 procedure codes in 2024, for 49 Medicare patients. Medicare paid $9,896 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Dr. Fortuna in 2024. The largest group is under 65, with 25 patients. 61% of them have high blood pressure, and 35% have arthritis. 65% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fortuna's median patient age at 43, with 55% women.

In 2024, Dr. Fortuna wrote 3,954 Medicare Part D claims for 226 patients. 83% of them were for generic drugs. CMS names the drug for 3,364 of them, across 99 drugs with 11 or more claims each, at $303,076 in total drug cost. In 2023, CMS named 3,001 claims across 91 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Fortuna for performance year 2024, reported as part of a group. Dr. Fortuna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fortuna as offering telehealth.

Dmand AI links 36 papers to Dr. Fortuna, published from 2008 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Primary Health Care, Ambulatory Care and Health Care Surveys. Dr. Fortuna has published most often in J Gen Intern Med. Dr. Fortuna's most frequent co-authors are Brett W. Robbins, MD, John David Bisognano, MD and Enrico Caiola, MD.

CMS Open Payments shows 2 general payments to Dr. Fortuna from 2 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Sun Pharmaceutical Industries Inc. paid the most, $122.

Dmand AI lists 2 awards for Dr. Fortuna, most recently NCQA PCMH in 2015.

Dr. Fortuna graduated from Geisel School Of Medicine At Dartmouth in 2002. Dr. Fortuna is a member of AAPM and ACP.

Dr. Fortuna is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.